skip to main | skip to sidebar

Xcovery blog - kinase industry knowledge collected and sometimes analyzed

Showing posts with label Alliances. Show all posts
Showing posts with label Alliances. Show all posts

Wednesday, January 03, 2007

Collection of good alliance articles, courtesy of Kaufmann eVenturing

  1. Five Strategies for Partnering with Larger Companies

  2. Evaluating and Selecting a Strategic Partner

  3. Top Ten Questions about Biotech Strategic Alliances

Posted by Unknown at 11:43 AM No comments:
Labels: Alliances
Older Posts Home
Subscribe to: Posts (Atom)

Kinase Industry Biz News

Links

  • Multi-targeted Therapy
  • All things chromatin
  • Guide to biotech IP
  • IHOP - great protein db
  • Kinase research portal
  • Seeking Alpha - solid biotech investment insight
  • Decent but dated summary of kinase therapeutics
  • Biotech licensing blog
  • Research VEGF
  • Therapeutic Angiogenesis
  • Xcovery
  • Email Tim (sitehost)

Blog Roll

  • KinasePro
  • Bio Health Investor
  • Biotechnology Stocks
  • In the pipeline
  • Omics! Omics!
  • On Bio VC
  • Org Prep Daily (home of Milkshake)
  • The Curious Waveform
  • Tim's Personal Blog
  • Totally Medicinal
  • Whistling in the Wind

Cool liks

  • Pfizer's RTK animation
  • ArQule's c-Met animation

Kinase efforts you may not know of

  • Calistoga Pharma (PI-3 p110 delta)
  • Semafore (PI3)
  • KAI Pharma (PKC-delta)
  • Locus (p38 & unnamed multi-TK)
  • Pharmacyclics (Btk)
  • Coratus
  • Tigris Pharmaceuticals

Blog Archive

  • ▼  2012 (1)
    • ▼  March (1)
      • New blog
  • ►  2007 (33)
    • ►  March (5)
    • ►  February (8)
    • ►  January (20)
  • ►  2006 (54)
    • ►  December (5)
    • ►  November (34)
    • ►  October (15)

Google search

 
Web xcovery.blogspot.com

Sitemeter

Technorati

clustermap

Locations of visitors to this page

Cloud

Labels

  • 2007 (1)
  • ABT-737 (1)
  • Accelrys (1)
  • access (1)
  • Akt (2)
  • ALL (2)
  • Alliances (1)
  • Ambit (1)
  • AMG 706 (2)
  • AMGN (1)
  • AML (1)
  • Amphora (1)
  • Ariad (1)
  • ARRY (4)
  • ARRY-543 (1)
  • ARRY-797 (1)
  • Arxxant (1)
  • Aurora (2)
  • Avastin (3)
  • Aveon (1)
  • Axitinib (1)
  • Axl (1)
  • AZ (1)
  • basics (1)
  • Bayer (2)
  • Bcr-abl (1)
  • BI (1)
  • BI-2536 (1)
  • BIBF-1120 (1)
  • BIBW-2992 (1)
  • Biomira (1)
  • BMS (4)
  • BREL (1)
  • business models (1)
  • cancer (2)
  • CDK4 (2)
  • Celebrex (1)
  • Cephalon (1)
  • CGI (1)
  • chemo (1)
  • CML (1)
  • CML NVS (1)
  • cool (2)
  • Cox-2 (1)
  • CP-690550 (1)
  • CP-751871 (1)
  • Curagen (1)
  • CYC116 (1)
  • Cyclacel (3)
  • discovery (1)
  • DNA (10)
  • EGFR (3)
  • erb-b2 (2)
  • Exelixis (2)
  • finance (1)
  • Flt-3 (1)
  • Gleevec (5)
  • GSK (2)
  • HDI (1)
  • herceptin (2)
  • Icahn (1)
  • IGFR-1 (1)
  • IKK (1)
  • IMC-3G3 (1)
  • IMCL (4)
  • inflammation (1)
  • Innovive (1)
  • IPO (1)
  • Iressa (1)
  • IVGN (1)
  • JAK2 (1)
  • Jak3 (2)
  • Kit (1)
  • Lilly (1)
  • lung (1)
  • M+ A (1)
  • Market stats (1)
  • MDACC (1)
  • MEDI (1)
  • Mek (1)
  • Merck (1)
  • Merrimack (1)
  • Met (2)
  • MK-0457 (1)
  • mutations (1)
  • new targets (2)
  • Nexavar (5)
  • NVS (3)
  • ONXX (5)
  • OSIP (3)
  • OSU-03012 (1)
  • P3 (1)
  • p38 (4)
  • Pathways (1)
  • PCOP (1)
  • PDGFR (2)
  • pertuzumab (2)
  • PFE (3)
  • PI3 (3)
  • Pim (1)
  • PKC (1)
  • Plk (1)
  • ProIX (1)
  • prostate (1)
  • RA (3)
  • RCC (3)
  • Sanofi (1)
  • Scios (1)
  • SGX (3)
  • SGX-523 (2)
  • SNS-032 (1)
  • Sprycel (1)
  • Src (1)
  • Sunesis (1)
  • SUPG (1)
  • Sutent (5)
  • TAK1 (1)
  • Tarceva (3)
  • Targegen (1)
  • Targeted therapies (1)
  • Tasigna (1)
  • thyroid (1)
  • Torisel (1)
  • trials (1)
  • Tykerb (3)
  • VEGF (2)
  • VEGFR (1)
  • VRTX (1)
  • VX-680 (1)
  • WYE (1)
  • Wyeth (1)
  • Xcovery (1)
  • XL518 (1)
  • XL999 (1)

Feeds

Add to Google

 

AMZN Omakase